Company Filing History:
Years Active: 1992-1993
Title: Inventor Profile: Michel E Begin from Nova Scotia, CA
Introduction
Michel E Begin is an accomplished inventor based in Nova Scotia, Canada, known for his significant contributions to medical science. With two patents to his name, his work prominently features innovative compositions aimed at advancing treatment options for cancer.
Latest Patents
Michel's latest patents focus on iron-containing compositions and methods for treating cancer. The first patent describes pharmaceutically acceptable compositions of one or more n-6 or n-3 essential fatty acids, particularly gamma-linolenic acid, dihomo-gamma-linolenic acid, or eicosapentaenoic acid, combined with assimilable iron compounds. The formulations are designed in dosage unit form, optionally incorporating a diluent or carrier. These compositions contain specific amounts of the acids or their derivatives and iron compounds, making them suitable for daily administration.
The second patent elaborates further on the same innovative approaches, reinforcing his commitment to exploring the therapeutic potential of essential fatty acids alongside iron compounds in cancer treatment.
Career Highlights
Michel E Begin is associated with Efamol Limited, where he continues to research and develop his pioneering ideas. His dedication to innovation in the field of medical treatments marks him as a prominent figure among contemporary inventors.
Collaborations
Working alongside his colleague David F Horrobin, Michel fosters a collaborative environment that encourages the exchange of ideas and expertise. Their joint efforts underscore the importance of teamwork in driving forward innovative solutions in healthcare.
Conclusion
Michel E Begin exemplifies the spirit of innovation in the medical sector with his groundbreaking patents focused on cancer treatment. His work not only highlights his ingenuity as an inventor but also contributes to the broader landscape of medical research aimed at improving patient outcomes.